The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

13 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Novel Indazole Compounds as TEAD Inhibitors for Treating Cancer.EBI
Smith, Gambrell & Russell
Novel Compounds as TEAD Inhibitors for Treating Cancer.EBI
Smith, Gambrell & Russell
A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunities.EBI
Shanghai Institute of Materia Medica
Chloroacetamide fragment library screening identifies new scaffolds for covalent inhibition of the TEAD·YAP1 interaction.EBI
Indiana University School of Medicine 635 Barnhill Drive
Small-Molecule Cyanamide Pan-TEAD·YAP1 Covalent Antagonists.EBI
Indiana University
Optimization of TEAD P-Site Binding Fragment Hit into In Vivo Active Lead EBI
Merck Healthcare
Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket.EBI
Max Planck Institute of Molecular Physiology
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.EBI
University of Bristol
Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein Interaction.EBI
Roche Innovation Center Shanghai
Targeting Transcriptional Enhanced Associate Domains (TEADs).EBI
Universities of Lille
PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEINBDB
Novartis
UNIT DOSAGE COMPOSITION OF AKT INHIBITORBDB
Nanjing Chia Tai Tianqing Pharmaceutical
Tricyclic amine compounds as CDK2 inhibitorsBDB
Incyte